Annual Accounts Receivable
$177.46 M
-$24.80 M-12.26%
March 31, 2024
Summary
- As of February 9, 2025, TARO annual accounts receivable is $177.46 million, with the most recent change of -$24.80 million (-12.26%) on March 31, 2024.
- During the last 3 years, TARO annual accounts receivable has fallen by -$36.08 million (-16.89%).
Performance
TARO Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
$177.46 M
-$13.77 M-7.20%
March 31, 2024
Summary
- As of February 9, 2025, TARO quarterly accounts receivable is $177.46 million, with the most recent change of -$13.77 million (-7.20%) on March 31, 2024.
- Over the past year, TARO quarterly accounts receivable has dropped by -$13.77 million (-7.20%).
Performance
TARO Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
TARO Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.3% | -7.2% |
| 3 y3 years | -16.9% | -16.9% |
| 5 y5 years | -25.4% | -21.9% |
TARO Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -28.1% | at low | -33.2% | at low |
| 5 y | 5-year | -28.1% | at low | -33.2% | at low |
| alltime | all time | -28.1% | -84.6% | -38.8% | -84.6% |
Taro Pharmaceutical Industries Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | $177.46 M(-12.3%) | $177.46 M(-7.2%) |
| Dec 2023 | - | $191.23 M(+5.6%) |
| Sep 2023 | - | $181.06 M(-20.2%) |
| Jun 2023 | - | $226.87 M(+12.2%) |
| Mar 2023 | $202.26 M(-18.1%) | $202.26 M(-18.6%) |
| Sep 2022 | - | $248.50 M(-6.5%) |
| Jun 2022 | - | $265.86 M(+7.6%) |
| Mar 2022 | $246.97 M(+15.7%) | $246.97 M(+9.9%) |
| Dec 2021 | - | $224.67 M(+14.2%) |
| Sep 2021 | - | $196.67 M(-9.3%) |
| Jun 2021 | - | $216.83 M(+1.5%) |
| Mar 2021 | $213.54 M(-9.2%) | $213.54 M(-6.7%) |
| Dec 2020 | - | $228.82 M(-1.2%) |
| Sep 2020 | - | $231.67 M(+22.4%) |
| Jun 2020 | - | $189.30 M(-19.5%) |
| Mar 2020 | $235.22 M(-1.1%) | $235.22 M(+3.5%) |
| Dec 2019 | - | $227.33 M(-8.2%) |
| Sep 2019 | - | $247.50 M(+15.9%) |
| Jun 2019 | - | $213.51 M(-10.3%) |
| Mar 2019 | $237.94 M(+15.3%) | $237.94 M(+6.3%) |
| Dec 2018 | - | $223.79 M(-0.1%) |
| Sep 2018 | - | $224.01 M(+7.1%) |
| Jun 2018 | - | $209.13 M(+1.3%) |
| Mar 2018 | $206.46 M(+1.2%) | $206.46 M(+4.4%) |
| Dec 2017 | - | $197.80 M(-1.9%) |
| Sep 2017 | - | $201.71 M(+8.5%) |
| Jun 2017 | - | $185.88 M(-8.8%) |
| Mar 2017 | $203.92 M(-14.5%) | $203.92 M(-19.0%) |
| Dec 2016 | - | $251.62 M(+0.7%) |
| Sep 2016 | - | $249.75 M(-13.8%) |
| Jun 2016 | - | $289.80 M(+21.5%) |
| Mar 2016 | $238.61 M(+7.3%) | $238.61 M(-14.6%) |
| Dec 2015 | - | $279.54 M(+13.0%) |
| Sep 2015 | - | $247.28 M(+25.7%) |
| Jun 2015 | - | $196.79 M(-11.5%) |
| Mar 2015 | $222.43 M(+60.3%) | $222.43 M(-1.4%) |
| Dec 2014 | - | $225.65 M(+26.3%) |
| Sep 2014 | - | $178.73 M(+72.6%) |
| Jun 2014 | - | $103.53 M(-25.4%) |
| Mar 2014 | $138.77 M | $138.77 M(+9.3%) |
| Dec 2013 | - | $127.01 M(-0.2%) |
| Sep 2013 | - | $127.32 M(+9.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2013 | - | $116.60 M(-2.7%) |
| Mar 2013 | $119.81 M(+7.8%) | $119.81 M(-11.0%) |
| Dec 2012 | - | $134.59 M(+3.3%) |
| Sep 2012 | - | $130.28 M(+8.4%) |
| Jun 2012 | - | $120.24 M(+8.2%) |
| Mar 2012 | $111.13 M(-8.0%) | $111.13 M(-8.0%) |
| Dec 2011 | $120.83 M(+64.6%) | $120.83 M(+17.7%) |
| Sep 2011 | - | $102.66 M(+23.5%) |
| Jun 2011 | - | $83.14 M(-38.2%) |
| Mar 2011 | - | $134.58 M(+83.3%) |
| Dec 2010 | $73.41 M(+19.1%) | $73.41 M(-27.9%) |
| Sep 2010 | - | $101.84 M(+3.4%) |
| Jun 2010 | - | $98.51 M(+59.8%) |
| Dec 2009 | $61.64 M(-0.7%) | $61.64 M(-40.2%) |
| Sep 2009 | - | $103.02 M(+3.3%) |
| Jun 2009 | - | $99.72 M(+26.3%) |
| Mar 2009 | - | $78.97 M(+27.2%) |
| Dec 2008 | $62.10 M(-11.3%) | $62.10 M(-42.1%) |
| Sep 2008 | - | $107.31 M(+108.9%) |
| Dec 2007 | $70.02 M(+77.5%) | - |
| Dec 2006 | $39.46 M(-23.2%) | - |
| Dec 2005 | $51.37 M(-58.8%) | $51.37 M(-63.3%) |
| Sep 2005 | - | $139.84 M(+0.6%) |
| Jun 2005 | - | $138.97 M(+6.9%) |
| Mar 2005 | - | $129.96 M(+4.2%) |
| Dec 2004 | $124.67 M(+3.4%) | $124.67 M(+22.3%) |
| Sep 2004 | - | $101.98 M(-14.1%) |
| Jun 2004 | - | $118.68 M(-14.1%) |
| Mar 2004 | - | $138.12 M(+14.6%) |
| Dec 2003 | $120.52 M(+74.6%) | $120.52 M(+14.0%) |
| Sep 2003 | - | $105.68 M(+29.5%) |
| Jun 2003 | - | $81.63 M(+14.0%) |
| Mar 2003 | - | $71.62 M(+3.7%) |
| Dec 2002 | $69.04 M(+67.8%) | $69.04 M(+22.7%) |
| Sep 2002 | - | $56.28 M(-7.7%) |
| Jun 2002 | - | $60.96 M(+27.0%) |
| Mar 2002 | - | $47.99 M(+16.7%) |
| Dec 2001 | $41.13 M(+6.4%) | $41.13 M(-0.0%) |
| Sep 2001 | - | $41.14 M(-12.2%) |
| Jun 2001 | - | $46.85 M(+5.9%) |
| Mar 2001 | - | $44.23 M(+14.4%) |
| Dec 2000 | $38.67 M(+41.1%) | $38.67 M(+41.1%) |
| Dec 1999 | $27.41 M | $27.41 M |
FAQ
- What is Taro Pharmaceutical Industries annual accounts receivable?
- What is the all time high annual accounts receivable for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries annual accounts receivable year-on-year change?
- What is Taro Pharmaceutical Industries quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries quarterly accounts receivable year-on-year change?
What is Taro Pharmaceutical Industries annual accounts receivable?
The current annual accounts receivable of TARO is $177.46 M
What is the all time high annual accounts receivable for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high annual accounts receivable is $246.97 M
What is Taro Pharmaceutical Industries annual accounts receivable year-on-year change?
Over the past year, TARO annual accounts receivable has changed by -$24.80 M (-12.26%)
What is Taro Pharmaceutical Industries quarterly accounts receivable?
The current quarterly accounts receivable of TARO is $177.46 M
What is the all time high quarterly accounts receivable for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high quarterly accounts receivable is $289.80 M
What is Taro Pharmaceutical Industries quarterly accounts receivable year-on-year change?
Over the past year, TARO quarterly accounts receivable has changed by -$13.77 M (-7.20%)